Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Testosterone and Anastrozole Implant in Premenopausal Women
NCT03314298Phase 1Completed
- Sponsor
- Havah Therapeutics
- Start
- Aug 2017
- Primary completion
- Apr 2018
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of testosterone and anastrozole, sponsored by Havah Therapeutics. Primary endpoints: testosterone Cmax at Day 85, testosterone AUC at Day 85 and 4 more. Started Aug 2017; status: completed.
02
Drugs
testosteroneanastrozole
Beyond the preview
Go deeper on NCT03314298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03314298.